{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:23Z","timestamp":1787020643674,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470203"],"award-info":[{"award-number":["82470203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Province Health Scientific Research Innovation Capacity Building Program","award":["2023TD-03"],"award-info":[{"award-number":["2023TD-03"]}]},{"name":"Xijing Hospital Talent Development and Facilitation Program","award":["XJZT24LY43"],"award-info":[{"award-number":["XJZT24LY43"]}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2025SF-YBXM-361"],"award-info":[{"award-number":["2025SF-YBXM-361"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07749-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:55:41Z","timestamp":1769529341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Zalcitabine induces ferroptosis in multiple myeloma through the TFAM\u2013cGAS\u2013STING\u2013SLC7A11 axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Juan","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"7749_CR1","doi-asserted-by":"publisher","first-page":"101120","DOI":"10.1016\/j.gendis.2023.101120","volume":"11","author":"H Huang","year":"2024","unstructured":"Huang H, Li Y, Zhu Z, Liu Y, Wang W, Chen S, Wu X, Wang Y, Chen Y, Lin H, Liang Y, Shu L. A new autophagy-related nomogram and mechanism in multiple myeloma. Genes Dis. 2024;11:101120.","journal-title":"Genes Dis"},{"key":"7749_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","volume":"5","author":"Q Lu","year":"2024","unstructured":"Lu Q, Yang D, Li H, Niu T, Tong A. Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed. 2024;5:25.","journal-title":"Mol Biomed"},{"key":"7749_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2023-174177","volume":"142","author":"S Bird","year":"2023","unstructured":"Bird S, Pawlyn C. IMiD resistance in multiple myeloma: current Understanding of the underpinning biology and clinical impact. Blood. 2023;142:131\u201340.","journal-title":"Blood"},{"key":"7749_CR4","first-page":"2420","volume":"109","author":"M Engelhardt","year":"2024","unstructured":"Engelhardt M, Kort\u00fcm KM, Goldschmidt H, Merz M. Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible. Haematologica. 2024;109:2420\u201335.","journal-title":"Haematologica"},{"key":"7749_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12967-023-04498-5","volume":"21","author":"C Rocca","year":"2023","unstructured":"Rocca C, Soda T, De Francesco EM, Fiorillo M, Moccia F, Viglietto G, Angelone T, Amodio N. Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer. J Transl Med. 2023;21:635.","journal-title":"J Transl Med"},{"key":"7749_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","volume":"10","author":"H Du","year":"2025","unstructured":"Du H, Xu T, Yu S, Wu S, Zhang J. Mitochondrial metabolism and cancer therapeutic innovation. Signal Transduct Target Ther. 2025;10:245.","journal-title":"Signal Transduct Target Ther"},{"key":"7749_CR7","doi-asserted-by":"publisher","first-page":"145706","DOI":"10.1016\/j.ijbiomac.2025.145706","volume":"319","author":"M Yang","year":"2025","unstructured":"Yang M, Sun L, Feng X, Xu W. Mitochondrial transcription factor a as a guardian of mitochondrial integrity and emerging therapeutic target in human diseases: A review. Int J Biol Macromol. 2025;319:145706.","journal-title":"Int J Biol Macromol"},{"key":"7749_CR8","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1038\/s41388-025-03467-0","volume":"44","author":"J Zhao","year":"2025","unstructured":"Zhao J, Cui M, Yao X, Jiang Z, Qi L, Chen J, Fan C, Bai S, Zhou C, Wei R, Liu H, Yang Q, Wan L, Bao D. Targeting TFAM downregulation mediated mtDNA-NLRP3 pathway suppresses TAM infiltration and HCC progression. Oncogene. 2025;44:2956\u201369.","journal-title":"Oncogene"},{"key":"7749_CR9","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1038\/s41388-022-02365-z","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Yang Q, Chen H, Yang X, Han J, Yao X, Wei X, Si J, Yao H, Liu H, Wan L, Yang H, Wang Y, Bao D. TFAM downregulation promotes autophagy and ESCC survival through MtDNA stress-mediated STING pathway. Oncogene. 2022;41:3735\u201346.","journal-title":"Oncogene"},{"key":"7749_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/cac2.12184","volume":"41","author":"S Yang","year":"2021","unstructured":"Yang S, He X, Zhao J, Wang D, Guo S, Gao T, Wang G, Jin C, Yan Z, Wang N, Wang Y, Zhao Y, Xing J, Huang Q. Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis-associated cancer. Cancer Commun (Lond). 2021;41:695\u2013714.","journal-title":"Cancer Commun (Lond)"},{"key":"7749_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.20892\/j.issn.2095-3941.2020.0151","volume":"18","author":"H Ni","year":"2021","unstructured":"Ni H, Guo M, Zhang X, Jiang L, Tan S, Yuan J, Cui H, Min Y, Zhang J, Schlisio S, Ma C, Liao W, Nister M, Chen C, Li S, Li N. VEGFR2 Inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis. Cancer Biol Med. 2021;18:139\u201354.","journal-title":"Cancer Biol Med"},{"key":"7749_CR12","doi-asserted-by":"publisher","first-page":"176999","DOI":"10.1016\/j.ejphar.2024.176999","volume":"984","author":"M Zheng","year":"2024","unstructured":"Zheng M, Jiang Q, You J, Gao B, Cui W, Yao W, Su F, Sun X, La L. Myricanol represses renal fibrosis by activating TFAM and ZNRF1 to inhibit tubular epithelial cells ferroptosis. Eur J Pharmacol. 2024;984:176999.","journal-title":"Eur J Pharmacol"},{"key":"7749_CR13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2165\/00003495-199244040-00009","volume":"44","author":"R Whittington","year":"1992","unstructured":"Whittington R, Brogden RN. Zalcitabine. A review of its Pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS). Drugs. 1992;44:656\u201383.","journal-title":"Drugs"},{"key":"7749_CR14","first-page":"1859","volume":"18","author":"E Ullyatt","year":"1998","unstructured":"Ullyatt E, Liang BC. 2\u2019,3\u2019-Dideoxycytidine is a potent inducer of apoptosis in glioblastoma cells. Anticancer Res. 1998;18:1859\u201363.","journal-title":"Anticancer Res"},{"key":"7749_CR15","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1182\/blood-2016-10-741207","volume":"129","author":"SU Liyanage","year":"2017","unstructured":"Liyanage SU, Hurren R, Voisin V, Bridon G, Wang X, Xu C, MacLean N, Siriwardena TP, Gronda M, Yehudai D, Sriskanthadevan S, Avizonis D, Shamas-Din A, Minden MD, Bader GD, Laposa R, Schimmer AD. Leveraging increased cytoplasmic nucleoside kinase activity to target MtDNA and oxidative phosphorylation in AML. Blood. 2017;129:2657\u201366.","journal-title":"Blood"},{"key":"7749_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1080\/15548627.2020.1739447","volume":"17","author":"C Li","year":"2021","unstructured":"Li C, Zhang Y, Liu J, Kang R, Klionsky DJ, Tang D. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. Autophagy. 2021;17:948\u201360.","journal-title":"Autophagy"},{"key":"7749_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12967-023-04370-6","volume":"21","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Fan X, Zhang X, Ju S. Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs. J Transl Med. 2023;21:514.","journal-title":"J Transl Med"},{"key":"7749_CR18","doi-asserted-by":"crossref","unstructured":"Ding K, Zhang L, Zhang Y, Jing Y, Liao H, Chen R, Meng Q. TFAM deficiency triggers mtDNA leakage and cGAS-STING-mediated intestinal ischemia\u2013reperfusion injury. Inflammation. 2025.","DOI":"10.1007\/s10753-025-02302-8"},{"key":"7749_CR19","doi-asserted-by":"crossref","unstructured":"Behera BP, Mishra SR, Patra S, Mahapatra KK, Bhol CS, Panigrahi DP, Praharaj PP, Klionsky DJ, Bhutia SK. Molecular regulation of mitophagy signaling in tumor microenvironment and its targeting for cancer therapy. Cytokine Growth Factor Rev. 2025.","DOI":"10.1016\/j.cytogfr.2025.01.004"},{"key":"7749_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41571-025-01041-x","volume":"22","author":"MA Dimopoulos","year":"2025","unstructured":"Dimopoulos MA, Terpos E, Boccadoro M, Moreau P, Mateos MV, Zweegman S, Cook G, Engelhardt M, Delforge M, Hajek R, Schjesvold F, Gay F, Manier S, Weisel KC, Kaiser M, van de Donk N, Zamagni E, Rodriguez-Otero P, Perrot A, Driessen C, Bila J, Laane E, Dytfeld D, Touzeau C, Beksac M, Raab MS, Cavo M, Mohty M, Spencer A, Ludwig H, Einsele H, San-Miguel J, Sonneveld P. Evidence-Based guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma. Nat Rev Clin Oncol. 2025;22:680\u2013700.","journal-title":"Nat Rev Clin Oncol"},{"key":"7749_CR21","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/s41467-025-56486-6","volume":"16","author":"H Hosoya","year":"2025","unstructured":"Hosoya H, Carleton M, Tanaka K, Sworder B, Syal S, Sahaf B, Maltos AM, Silva O, Stehr H, Hovanky V, Duran G, Zhang T, Liedtke M, Arai S, Iberri D, Miklos D, Khodadoust MS, Sidana S, Kurtz DM. Deciphering response dynamics and treatment resistance from Circulating tumor DNA after CAR T-cells in multiple myeloma. Nat Commun. 2025;16:1824.","journal-title":"Nat Commun"},{"key":"7749_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2165\/00003088-199528050-00002","volume":"28","author":"D Devineni","year":"1995","unstructured":"Devineni D, Gallo JM. Zalcitabine. Clinical pharmacokinetics and efficacy. Clin Pharmacokinet. 1995;28:351\u201360.","journal-title":"Clin Pharmacokinet"},{"key":"7749_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/106002809302700416","volume":"27","author":"MJ Shelton","year":"1993","unstructured":"Shelton MJ, O\u2019Donnell AM, Morse GD. Zalcitabine Ann Pharmacother. 1993;27:480\u20139.","journal-title":"Zalcitabine Ann Pharmacother"},{"key":"7749_CR24","doi-asserted-by":"publisher","first-page":"122574","DOI":"10.1016\/j.biomaterials.2024.122574","volume":"309","author":"M Chen","year":"2024","unstructured":"Chen M, Tong X, Sun Y, Dong C, Li C, Wang C, Zhang M, Wen Y, Ye P, Li R, Wan J, Liang S, Shi S. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy. Biomaterials. 2024;309:122574.","journal-title":"Biomaterials"},{"key":"7749_CR25","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41388-024-03020-5","volume":"43","author":"H Jiang","year":"2024","unstructured":"Jiang H, Wang L, Zhang Q, Wang S, Jia L, Cheng H, Wang J, Li X, Xie Y, Wang Y, Hu M, Guo J, Li Q, Peng Z, Wang M, Xie Y, Li T, Wang Y, Geng BD, Swaminathan S, Bergsagel PL, Liu Z. Bone marrow stromal cells dictate lanosterol biosynthesis and ferroptosis of multiple myeloma. Oncogene. 2024;43:1644\u201353.","journal-title":"Oncogene"},{"key":"7749_CR26","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1182\/bloodadvances.2023010335","volume":"8","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu Y, Zuo L, Fan F, Yan H, Zhao F, Li J, Ma C, Li Q, Xu A, Xu J, Zhang B, Hu Y, Sun C. Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma. Blood Adv. 2024;8:5022\u201338.","journal-title":"Blood Adv"},{"key":"7749_CR27","doi-asserted-by":"crossref","unstructured":"Wu Y, Lu WM, Cui QR, Zhou J, Lu GD. Metabolic regulation of cGAS-STING signaling in the tumor microenvironment: Dual immune roles and therapeutic implications. Cytokine Growth Factor Rev. 2025.","DOI":"10.1016\/j.cytogfr.2025.06.002"},{"key":"7749_CR28","doi-asserted-by":"crossref","unstructured":"Ding L, Zhang R, Du W, Wang Q, Pei D. The role of cGAS-STING signaling pathway in ferroptosis. J Adv Res. 2024.","DOI":"10.1016\/j.jare.2024.12.028"},{"key":"7749_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2022.10.004","volume":"193","author":"S Zhang","year":"2022","unstructured":"Zhang S, Kang L, Dai X, Chen J, Chen Z, Wang M, Jiang H, Wang X, Bu S, Liu X, Zhang G, Tang H. Manganese induces tumor cell ferroptosis through type-I IFN dependent Inhibition of mitochondrial dihydroorotate dehydrogenase. Free Radic Biol Med. 2022;193:202\u201312.","journal-title":"Free Radic Biol Med"},{"key":"7749_CR30","doi-asserted-by":"publisher","first-page":"113968","DOI":"10.1016\/j.intimp.2024.113968","volume":"147","author":"D Liao","year":"2025","unstructured":"Liao D, Cui Y, Shi L, Zeng S, Wang H. USP34 regulates PIN1-cGAS-STING axis-dependent ferroptosis in cervical cancer via sumoylation. Int Immunopharmacol. 2025;147:113968.","journal-title":"Int Immunopharmacol"},{"key":"7749_CR31","doi-asserted-by":"publisher","first-page":"16235","DOI":"10.1021\/acs.jmedchem.4c01065","volume":"67","author":"Y Li","year":"2024","unstructured":"Li Y, Liu B, Zheng Y, Hu M, Liu LY, Li CR, Zhang W, Lai YX, Mao ZW. Photoinduction of ferroptosis and cGAS-STING activation by a H(2)S-Responsive Iridium(III) complex for Cancer-Specific therapy. J Med Chem. 2024;67:16235\u201347.","journal-title":"J Med Chem"},{"key":"7749_CR32","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood.2024026040","volume":"145","author":"L He","year":"2025","unstructured":"He L, Zhao T, Leong WZ, Sharda A, Mayerhofer C, Mei S, Bonilla GM, Menendez-Gonzalez JB, Gustafsson K, Fukushima T, Kristiansen TA, Lee JW, Xu Y, Chen L, Xia J, Orozco LA, Budnik B, Sadreyev R, Dou Z, Sykes DB, Scadden DT. PSTK Inhibition activates cGAS-STING, precipitating ferroptotic cell death in leukemic stem cells. Blood. 2025;145:1903\u201314.","journal-title":"Blood"},{"key":"7749_CR33","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/s41467-025-57257-z","volume":"16","author":"X Ran","year":"2025","unstructured":"Ran X, Wu BX, Vidhyasagar V, Song L, Zhang X, Ladak RJ, Teng M, Ba-Alawi W, Philip V, He HH, Sonenberg N, Lok BH. PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer. Nat Commun. 2025;16:2166.","journal-title":"Nat Commun"},{"key":"7749_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12929-025-01187-x","volume":"32","author":"H Jiang","year":"2025","unstructured":"Jiang H, Liu L, He S, Qu S, Yang Y, Kang G, Wu M, Liu H, Zhang Y, Wang Z, Tian W, Chen Y, Wang L, Wang Q, Ye T, Han J, Wang H, Huang Y. Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor immunity by activating mtDNA-cGAS-STING pathway. J Biomed Sci. 2025;32:92.","journal-title":"J Biomed Sci"},{"key":"7749_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-025-01727-w","volume":"18","author":"J Huang","year":"2025","unstructured":"Huang J, Pham VT, Fu S, Huang G, Liu YG, Zheng L. Mitophagy\u2019s impacts on cancer and neurodegenerative diseases: implications for future therapies. J Hematol Oncol. 2025;18:78.","journal-title":"J Hematol Oncol"},{"key":"7749_CR36","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/2159-8290.CD-22-0601","volume":"13","author":"C Glytsou","year":"2023","unstructured":"Glytsou C, Chen X, Zacharioudakis E, Al-Santli W, Zhou H, Nadorp B, Lee S, Lasry A, Sun Z, Papaioannou D, Cammer M, Wang K, Zal T, Zal MA, Carter BZ, Ishizawa J, Tibes R, Tsirigos A, Andreeff M, Gavathiotis E, Aifantis I. Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia. Cancer Discov. 2023;13:1656\u201377.","journal-title":"Cancer Discov"},{"key":"7749_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12929-024-01101-x","volume":"32","author":"X Gao","year":"2025","unstructured":"Gao X, Feng Q, Zhang Q, Zhang Y, Hu C, Zhang L, Zhang H, Wang G, Hu K, Ma M, Wang Z, Liu Y, An D, Yi H, Peng Y, Wu X, Chen G, Jia X, Cai H, Shi J. Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ\/Parkin axis. J Biomed Sci. 2025;32:9.","journal-title":"J Biomed Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07749-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:55:01Z","timestamp":1771422901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07749-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7749"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07749-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical samples of MM were collected complied with the Declaration of Helsinki. All patients provided written informed consent, and the study protocol was approved by the Human Research Protection Committee of Xijing Hospital(Approval No. KY20243348-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors contributed to the development of the manuscript and agreed to the content of the final version.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare there was no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}